Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Peters Jennifer C

2. Date of Event Requiring Statement (MM/DD/YYYY) 1/1/2018

3. Issuer Name and Ticker or Trading Symbol

LIFEPOINT HEALTH, INC. [LPNT]

(Last) (First) (Middle)

330 SEVEN SPRINGS WAY

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
Gen. Counsel and Corp. Sec. /

(Street)

BRENTWOOD, TN 37027

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Non-Qualified Stock Options (Right to buy)	⁽¹⁾	6/6/2027	Common	9630.0000	$61.4500	D
Non-Qualified Stock Options (Right to buy)	⁽²⁾	2/23/2026	Common	8974.0000	$64.2200	D
Non-Qualified Stock Options (Right to buy)	⁽²⁾	2/28/2027	Common	7254.0000	$64.5000	D
Non-Qualified Stock Options (Right to buy)	⁽²⁾	2/24/2025	Common	7000.0000	$71.0000	D
Restricted Stock Units	⁽³⁾	⁽³⁾	Common	6792.0000	$0.0000	D

Explanation of Responses:
(1)	The options vest in four equal installments beginning on the first anniversary of the date of grant.
(2)	The options vest in three equal installments beginning on the first anniversary of the date of grant.
(3)	Each RSU represents the right to receive one share of Common Stock upon vesting. 617 of the RSUs will vest on February 24, 2018. 1,616 of the RSUs vest ratably over two years, beginning February 23, 2018. 1,959 of the RSUs vest ratably over three years, beginning on February 28, 2018. 2,600 of the RSUs vest ratably over four years, beginning on June 6, 2018.

Remarks:
peterspoa.txt

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Peters Jennifer C 330 SEVEN SPRINGS WAY BRENTWOOD, TN 37027			Gen. Counsel and Corp. Sec.

Signatures
/s/ Kathy Teague, Attorney-in-Fact		1/10/2018
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.